Skip to content

Share Buybacks at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$250.1M+8.8%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$50.05M
Globus Medical logo
Globus MedicalGMED
$0-100%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$6.37M
Avanos Medical logo
Avanos MedicalAVNS
$1.3M-40.9%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$460K-23.5%

Other financials

Income statement

See full
Revenue$29.6M+13.2%
Net income-$5.1M-3.8%

Balance sheet

See full
Cash & equivalents$41.0M-23.1%
Total debt$25.7M+1.2%
Total equity$133.9M-9.8%
Total assets$179.4M-5.9%

Cash flow

See full
Operating cash flow-$4.8M-3,628%
CapEx$1.4M-49.3%
Free cash flow-$6.3M-112%

Valuation

See full
Market cap$204.37M+31.6%
Enterprise value$189.09M+48.7%
P/S1.8×+0.1×

Profitability

See full
Net margin-9.8%-4.4pp
FCF margin0.9%

Returns & leverage

See full
Return on equity-8%-3.4pp
Debt / equity0.2×0.0×
Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anika Therapeutics's share buybacks?
Anika Therapeutics (ANIK) reported share buybacks of $8.69M in Q1 2026.
How has Anika Therapeutics's share buybacks changed year-over-year?
Anika Therapeutics's share buybacks increased by 118.8% year-over-year, from $3.97M to $8.69M.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.